---
document_datetime: 2023-09-21 18:59:41
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_en.pdf
document_name: imprida-hct-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 5.817342
conversion_datetime: 2025-12-28 18:25:27.456833
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength             | Pharmaceutical Form   | Route of Administration   | Packaging          | Package size                        |
|-----------------|-----------------|----------------------|-----------------------|---------------------------|--------------------|-------------------------------------|
| EU/1/09/570/001 | Imprida HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 14 tablets                          |
| EU/1/09/570/002 | Imprida HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 28 tablets                          |
| EU/1/09/570/003 | Imprida HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 30 tablets                          |
| EU/1/09/570/004 | Imprida HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 56 tablets                          |
| EU/1/09/570/005 | Imprida HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 90 tablets                          |
| EU/1/09/570/006 | Imprida HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 98 tablets                          |
| EU/1/09/570/007 | Imprida HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 tablets                         |
| EU/1/09/570/008 | Imprida HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 56 x 1 tablet                       |
| EU/1/09/570/009 | Imprida HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 98 x 1 tablet                       |
| EU/1/09/570/010 | Imprida HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 x 1 tablet                      |
| EU/1/09/570/011 | Imprida HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 x 1 (4 x 70) tablet (multipack) |
| EU/1/09/570/012 | Imprida HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 (20 x 14) tablets (multipack)   |
| EU/1/09/570/013 | Imprida HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 14 tablets                          |
| EU/1/09/570/014 | Imprida HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 28 tablets                          |
| EU/1/09/570/015 | Imprida HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 30 tablets                          |
| EU/1/09/570/016 | Imprida HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 56 tablets                          |
| EU/1/09/570/017 | Imprida HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 90 tablets                          |
| EU/1/09/570/018 | Imprida HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 98 tablets                          |
| EU/1/09/570/019 | Imprida HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 tablets                         |
| EU/1/09/570/020 | Imprida HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 56 x 1 tablet                       |
| EU/1/09/570/021 | Imprida HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 98 x 1 tablet                       |
| EU/1/09/570/022 | Imprida HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 x 1 tablet                      |
| EU/1/09/570/023 | Imprida HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 x 1 (4 x 70) tablet (multipack) |
| EU/1/09/570/024 | Imprida HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 (20 x 14) tablets (multipack)   |
| EU/1/09/570/025 | Imprida HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 14 tablets                          |
| EU/1/09/570/026 | Imprida HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 28 tablets                          |
| EU/1/09/570/027 | Imprida HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 30 tablets                          |
| EU/1/09/570/028 | Imprida HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 56 tablets                          |
| EU/1/09/570/029 | Imprida HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 90 tablets                          |
| EU/1/09/570/030 | Imprida HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 98 tablets                          |
| EU/1/09/570/031 | Imprida HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 tablets                         |

<div style=\"page-break-after: always\"></div>

| EU/1/09/570/032 EU/1/09/570/033   | Imprida HCT Imprida HCT   | 5 mg/160 mg/25 mg 5 mg/160 mg/25 mg   | Film-coated tablet Film-coated tablet   | Oral use Oral use   | blister (PVC/PVDC) blister (PVC/PVDC)   | 56 x 1 tablet 98 x 1 tablet                          |
|-----------------------------------|---------------------------|---------------------------------------|-----------------------------------------|---------------------|-----------------------------------------|------------------------------------------------------|
| EU/1/09/570/034                   |                           |                                       |                                         |                     | blister (PVC/PVDC)                      | 280 x 1 tablet                                       |
|                                   | Imprida HCT               | 5 mg/160 mg/25 mg                     | Film-coated tablet                      | Oral use            |                                         |                                                      |
| EU/1/09/570/035                   | Imprida HCT               | 5 mg/160 mg/25 mg                     | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 280 x 1 (4 x 70) tablet (multipack) 280 (20 x 14)    |
| EU/1/09/570/036                   | Imprida HCT               | 5 mg/160 mg/25 mg                     | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | tablets (multipack)                                  |
| EU/1/09/570/037                   | Imprida HCT               | 10 mg/160 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 14 tablets                                           |
| EU/1/09/570/038                   | Imprida HCT               | 10 mg/160 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 28 tablets                                           |
| EU/1/09/570/039                   | Imprida HCT               | 10 mg/160 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 30 tablets                                           |
| EU/1/09/570/040                   | Imprida HCT               | 10 mg/160 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 56 tablets                                           |
| EU/1/09/570/041                   | Imprida HCT               | 10 mg/160 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 90 tablets                                           |
| EU/1/09/570/042                   | Imprida HCT               | 10 mg/160 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 98 tablets                                           |
| EU/1/09/570/043                   | Imprida HCT               | 10 mg/160 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 280 tablets                                          |
| EU/1/09/570/044                   | Imprida HCT               | 10 mg/160 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 56 x 1 tablet                                        |
| EU/1/09/570/045                   | Imprida HCT               | 10 mg/160 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 98 x 1 tablet                                        |
| EU/1/09/570/046                   | Imprida HCT               | 10 mg/160 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 280 x 1 tablet                                       |
| EU/1/09/570/047                   | Imprida HCT               | 10 mg/160 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 280 x 1 (4 x 70) tablet (multipack)                  |
| EU/1/09/570/048                   | Imprida HCT               | 10 mg/160 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 280 (20 x 14) tablets (multipack)                    |
| EU/1/09/570/049                   | Imprida HCT               | 10 mg/320 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 14 tablets                                           |
| EU/1/09/570/050                   | Imprida HCT               | 10 mg/320 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 28 tablets                                           |
| EU/1/09/570/051                   | Imprida HCT               | 10 mg/320 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 30 tablets                                           |
| EU/1/09/570/052                   | Imprida HCT               | 10 mg/320 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 56 tablets                                           |
| EU/1/09/570/053                   | Imprida HCT               | 10 mg/320 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 90 tablets                                           |
| EU/1/09/570/054                   | Imprida HCT               | 10 mg/320 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 98 tablets                                           |
| EU/1/09/570/055                   | Imprida HCT               | 10 mg/320 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 280 tablets                                          |
| EU/1/09/570/056                   | Imprida HCT               | 10 mg/320 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 56 x 1 tablet                                        |
| EU/1/09/570/057                   | Imprida HCT Imprida HCT   | 10 mg/320 mg/25 mg 10 mg/320 mg/25 mg | Film-coated tablet Film-coated tablet   | Oral use            | blister (PVC/PVDC)                      | 98 x 1 tablet                                        |
| EU/1/09/570/058                   |                           |                                       |                                         | Oral use            | blister (PVC/PVDC)                      | 280 x 1 tablet                                       |
| EU/1/09/570/059                   | Imprida HCT               | 10 mg/320 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | 280 x 1 (4 x 70)                                     |
| EU/1/09/570/060                   | Imprida HCT               | 10 mg/320 mg/25 mg                    | Film-coated tablet                      | Oral use            | blister (PVC/PVDC)                      | tablet (multipack) 280 (20 x 14) tablets (multipack) |